Department of Pediatrics, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Department of Neonatology, Hefei Women and Child Health Care Hospital, Hefei, China.
BMC Pregnancy Childbirth. 2023 Sep 7;23(1):642. doi: 10.1186/s12884-023-05954-2.
The evidence on the associations of the timing of maternal gestational diabetes mellitus (GDM) with the comprehensive growth trajectory from perinatal to early childhood in offspring is limited. The potential mechanism remains elusive. Our aim is to estimate the associations of the timing of GDM diagnosis and gestational weight gains (GWG) with the growth trajectory of children from perinatal to early childhood.
A total of 7609 participants are included from the Maternal & Infants Health in Hefei cohort study. Primary predictors were the timing of maternal GDM diagnosis and GWG during pregnancy. The main outcomes included fetal ultrasonic measurements, birth size as well as BMI peak indicators during infancy within 48 months.
GDM diagnosed before 26 weeks was associated with increased risks of overgrowth for fetal abdominal circumference (OR 1.19, 95% CI 1.04-1.36) and birth weight (OR 1.51, 95% CI 1.19-1.91) when compared with unexposed. GDM diagnosis < 26 weeks was related to the higher BMI peak (β 0.16, 95%CI 0.03-0.28) within 48 months. The significantly additive impacts of maternal early GDM diagnosis and excessive gestational weight gains (EGWG) on offspring overgrowth were observed. Women in GDM < 26 weeks with early EGWG group had higher levels of hsCRP compared with GDM > 26 weeks (P < 0.001).
Exposure to maternal GDM diagnosed before 26 weeks with early EGWG could lead to shifts and/or disruptions from the typical growth trajectory from perinatal to early childhood in offspring.
关于母亲妊娠糖尿病(GDM)发病时间与后代围产期至幼儿期全面生长轨迹之间关联的证据有限,其潜在机制仍不清楚。我们的目的是评估 GDM 诊断和妊娠增重(GWG)时间与儿童从围产期到幼儿期的生长轨迹之间的关联。
本研究共纳入了来自合肥母婴健康队列研究的 7609 名参与者。主要预测因素为母亲 GDM 诊断和妊娠期间 GWG 的时间。主要结局包括胎儿超声测量、出生时的大小以及 48 个月内婴儿期的 BMI 峰值指标。
与未暴露组相比,26 周前诊断的 GDM 与胎儿腹围(OR 1.19,95%CI 1.04-1.36)和出生体重(OR 1.51,95%CI 1.19-1.91)的过度生长风险增加有关。<26 周的 GDM 诊断与 48 个月内更高的 BMI 峰值(β 0.16,95%CI 0.03-0.28)有关。观察到母亲早期 GDM 诊断和过度妊娠增重(EGWG)对后代过度生长的显著叠加影响。与 GDM>26 周的女性相比,<26 周的 GDM 伴早期 EGWG 的女性 hsCRP 水平更高(P<0.001)。
暴露于 26 周前诊断的 GDM 伴早期 EGWG 可能导致后代从围产期到幼儿期的典型生长轨迹发生偏移和/或中断。